YPYan Pang

Yan Pang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yan Pang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Surgeons’ Perceptions of Machine-learning‑based Prognostic Tools for Spine Surgery: A Qualitative Study (Preprint)

    by Zheng An Toh, Per Koren Solvang, Hwee Weng Dennis Hey, Wei How Darryl Ang, Yan Pang, Kanokwan Hounsri, Tore Solberg, Bjørnar Berg, Margreth Grotle, Minna Pikkarainen, et al.

  • Open Access

    Surgeons’ Perceptions of Machine-learning‑based Prognostic Tools for Spine Surgery: A Qualitative Study (Preprint)

    by Zheng An Toh, Per Koren Solvang, Hwee Weng Dennis Hey, Wei How Darryl Ang, Yan Pang, Kanokwan Hounsri, Tore Solberg, Bjørnar Berg, Margreth Grotle, Minna Pikkarainen, et al.

    BACKGROUND Machine-learning-enabled prognostic models are increasingly proposed to support surgical decision-making for degenerative lumbar disorders, yet their clinical adoption remains limited. Understanding how surgeons perceive these tools is critical for effective implementation, particularly given the high-stakes nature of spine surgery where decisions carry long-term functional consequences and medico-legal implications. OBJECTIVE This study aimed to explore how consultant-level spine surgeons perceive machine-learning-based prognostic tools, including their trustworthiness, clinical utility, usability, workflow integration, and implications for patient counselling and shared decision-making. METHODS A qualitative study using semi-structured one-to-one interviews was conducted with 11 consultant-level orthopaedic and neurosurgeons practising in Singapore (response rate: 73% of 15 invited). Participants had a mean of 10.9 years (range: 8-25 years) of spine surgery experience; 82% (n=9) were male. Interviews (range: 15-57 minutes) were transcribed verbatim and analysed using Braun and Clarke's six-step reflexive thematic analysis. Data collection continued until information power was achieved, with three additional interviews completed after thematic sufficiency was reached as participants had already consented. The study was designed and reported in accordance with COREQ criteria. RESULTS Three overarching themes were developed. Trust contingent on data integrity revealed that surgeons' confidence depended fundamentally on data quality, local representativeness, labelling credibility, and rigorous validation, with participants consistently emphasising population representativeness as a trust prerequisite. Surgeons operationalised trust through accessible performance metrics, with most identifying AUROC as their preferred credibility heuristic. Pragmatic orientation as important for implementation demonstrated that usability and seamless electronic health record integration were non-negotiable prerequisites, with surgeons explicitly stating that manual data entry would preclude adoption. Medico-legal concerns were prominent, with participants emphasising that decision responsibility remains with the clinician. Surgical decision-making as a delicate dance between art and science reflected how prognostic outputs were positioned as adjunctive inputs to be reconciled with experiential judgement and patient heterogeneity. Surgeons emphasised that identical prognostic information would be interpreted differently based on practice philosophy, and most highlighted the inherent divergence between technical success and patient-perceived success, underscoring prognostic tools' value for expectation management rather than deterministic prediction. CONCLUSIONS This first qualitative study of spine surgeons' perceptions reveals that adoption of machine-learning-based prognostic tools is contingent on data integrity, pragmatic workflow integration, and alignment with professional judgement and not predictive performance alone. Surgeons expressed cautious openness, viewing these tools as valuable in complex cases for clarifying outcome expectations without displacing clinical responsibility. Meaningful implementation requires robust data governance, contextually grounded validation, seamless electronic integration, and explicit positioning of machine learning as supportive rather than substitutive of surgical judgement. These findings provide empirically grounded guidance for developing clinically acceptable and implementation-ready prognostic decision support systems.

  • Experiences, support needs, and coping strategies of women with early-stage breast cancer in Singapore: A qualitative study

    by Yan Pang, Fong-Seng Lim, Marie Ann Mae En Wong, Samuel Guan-Wei Ow, Minna Pikkarainen, Swee-Ho Lim, Hong-Gu He

  • Open Access

    Participants’ Perspectives on the iCareBreast Mobile-Based Perioperative Care Program for Women Undergoing Breast Cancer Surgery: Qualitative Process Evaluation

    by Yan Pang, Honggu He, Minna Pikkarainen, Swee-Ho Lim

    Background: Breast cancer treatment, particularly during the perioperative period, is often accompanied by significant psychological distress, including anxiety and uncertainty. Mobile health (mHealth) interventions have emerged as promising tools to provide timely psychosocial support through convenient, flexible, and personalized platforms. While research has explored the use of mHealth in breast cancer prevention, care management, and survivorship, few studies have examined patients’ experiences with mobile interventions during the perioperative phase of breast cancer treatment. Objective: This study aimed to explore the experiences of patients with breast cancer using iCareBreast, a mobile app designed to provide perioperative guidance and psychosocial support. Methods: A qualitative approach was used to explore participant experiences. A total of 13 English- or Chinese-speaking participants from the intervention group of a clinical study were recruited via purposive sampling between April 2021 and February 2022. Semistructured individual phone interviews were conducted, audio-recorded, and transcribed verbatim. Thematic analysis was performed to identify key patterns of experience, focusing on usability, emotional impact, perceived value, and areas for future improvement. Results: Overall, 4 main themes and 11 subthemes emerged from this study: (1) navigating the app with confidence and comfort, (2) making sense of treatment through relevant and evolving content, (3) finding emotional anchors in a time of uncertainty, and (4) advocating for broader use and continued motivation. Participants found the app user-friendly and appreciated its structure and locally relevant content, which helped reduce anxiety and enhance surgical preparedness. Features such as deep breathing exercises, motivational quotes, survivor stories, mindfulness practices, and peer support links offered emotional comfort and a sense of companionship. Participants strongly advocated for more personalized and adaptive content aligned with their treatment type and recovery progress. They also emphasized the value of interactive elements, such as video demonstrations and accessing messaging functions, to support sustained engagement. Many expressed the need for extended support throughout the adjuvant treatment phases, including chemotherapy and radiotherapy. Conclusions: The iCareBreast app was perceived as a supportive tool during the perioperative period, helping patients navigate both informational and emotional challenges. However, the findings underscore the importance of extending content across the treatment continuum and enhancing personalization and interactivity. mHealth interventions should be responsive to patients’ evolving needs and integrated into clinical care pathways to provide timely, comprehensive, tailored, and ongoing support for women with breast cancer.

  • Open Access

    Patient and family engagement interventions in primary care patient safety: systematic review and meta-analysis of randomised controlled trials

    by Yan Pang, Anna Szuecs, Ignacio Ricci-Cabello, Jaheeda Gangannagaripalli, Lay Hoon Goh, Foon Leng Leong, Li Fan Zhou, Jose Maria Valderas

    Background: Engaging patients and families has been promoted as a key strategy for improving patient safety of health systems. However, evidence remains scarce on the effectiveness of this approach in primary care. Aim: To assess the combined effectiveness of primary care interventions in randomised controlled trials (RCTs) promoting patient and family engagement in patient safety. Design and setting: A systematic review and meta-analysis. Method: The review followed PRISMA and Cochrane guidelines. Five electronic databases (Medline, CINAHL, Embase, Web of Science, CENTRAL) were searched from inception to 18 September 2024 with keywords in four blocks (patient and family engagement; patient safety; primary care; randomised controlled trial). Patient and family engagement levels were appraised. Where appropriate, results were combined into meta-analyses. Results: Of the 19 included records, 12 reported on completed RCTs. Only one intervention integrated patients/families into overall care safety (high engagement); six aimed at enhancing skills and tools (intermediate), and 12 informed patients/families how to engage and prompted them to do it (low). RCTs primarily targeted medication safety, with meta-analyses showing no significant effects on reducing adverse drug events (odds ratio [OR] 0.86, 95% confidence interval [CI] = 0.70 to 1.08) or improving medication appropriateness measured categorically (OR 0.92, 95% CI = 0.76 to 1.13) or continuously (mean difference 0.71, 95% CI = −0.10 to 1.52). Overall risk of bias was low and certainty of evidence very low to moderate. Conclusion: Existing randomised controlled evidence on patient and family engagement in primary care remains inconclusive and limited in scope. Future interventions should include higher levels of engagement and address more diverse patient safety outcomes relevant for primary care.


  • Open Access

    Effectiveness of an Innovative Mobile-Based Perioperative Care Program for Women Undergoing Breast Cancer Surgery (iCareBreast): Randomized Controlled Trial

    by Yan Pang, Honggu He, Ruey-Pyng Ng, Nicole Kim Luan Lee, Me Me Win Htein, Xiao-Xin Zhao, Ying-Hong Li, Elizabeth Jiahui Chan, Lixia Zhu, Guang Yu Liu, et al.

    Background: Breast cancer is one of the most prevalent cancers among women and significantly impacts psychological well-being and health-related quality of life (HR-QoL) during the perioperative period. Mobile health interventions offer a promising approach to providing education and psychosocial support, yet their effectiveness in this context remains underexplored. Objective: This study aimed to develop and evaluate the effectiveness of an innovative, mobile-based, perioperative care program for women undergoing breast cancer surgery (iCareBreast). The assessment focused on perioperative self-efficacy, anxiety, depression, fatigue, HR-QoL, and perioperative care satisfaction. Methods: A two-group randomized control trial was conducted at a tertiary hospital in Singapore. The intervention group used the iCareBreast app, offering four main resources: perioperative care guidance, breast cancer and surgery education, psychological support, and social support. The control group received standard hospital care. Participants in the intervention group engaged with the fully automated app daily for 29 days (two weeks before surgery, on the day of surgery, and two weeks after surgery). Data were collected face-to-face or on the web at three time points: baseline, immediately after the intervention (T1; two weeks after surgery), and at a 2.5-month follow-up (T2; three months after surgery). The primary outcome was perioperative care self-efficacy, while secondary outcomes included anxiety, depression, fatigue, HR-QoL, and perioperative care satisfaction. Results: A total of 123 patients with early-stage breast cancer scheduled for breast surgery were enrolled in the study, with 62 patients assigned to the iCareBreast group and 61 patients to the control group. The results showed no significant differences between the groups in the primary outcome—perioperative self-efficacy—at any time point. Baseline scores were similar (P=.80), and while the iCareBreast group showed slightly lower scores at T1 (mean difference [MD] –1.63, 95% CI –3.43 to 0.18; P=.08) and T2 (MD –1.90, 95% CI –4.06 to 0.26; P=.09), the differences were not statistically significant. Similarly, secondary outcomes, including anxiety, depression, fatigue, HR-QoL, and perioperative care satisfaction, showed no significant changes between groups (all P>.05). However, the iCareBreast group reported higher perioperative care satisfaction during the postintervention assessment. Satisfaction scores were comparable at T1 (P=.68), while at T2, the iCareBreast group showed a slight increase compared to the control group (MD 0.35, 95% CI 0.04-0.73; P=.08), though the difference was not statistically significant. Conclusions: The mobile-based psychosocial intervention, although satisfied by users, did not demonstrate significant benefits compared to standard care. This highlights the need to refine the iCareBreast app in future iterations to enhance its effectiveness in addressing the targeted health outcomes. Future mobile health research should prioritize optimizing user engagement strategies and incorporating personalized approaches to better address the perioperative care needs of patients with breast cancer. Trial Registration: ClinicalTrials.gov NCT04172350; https://clinicaltrials.gov/study/NCT04172350


  • Open Access

    Participants’ Perspectives on the iCareBreast Mobile-Based Perioperative Care Program for Women Undergoing Breast Cancer Surgery: Qualitative Process Evaluation (Preprint)

    by Yan Pang, Honggu He, Minna Pikkarainen, Swee-Ho Lim

    BACKGROUND Breast cancer treatment, particularly during the perioperative period, is often accompanied by significant psychological distress, including anxiety and uncertainty. Mobile health (mHealth) interventions have emerged as promising tools to provide timely psychosocial support through convenient, flexible, and personalized platforms. While research has explored the use of mHealth in breast cancer prevention, care management, and survivorship, few studies have examined patients’ experiences with mobile interventions during the perioperative phase of breast cancer treatment. OBJECTIVE This study aimed to explore the experiences of patients with breast cancer using iCareBreast, a mobile app designed to provide perioperative guidance and psychosocial support. METHODS A qualitative approach was used to explore participant experiences. A total of 13 English- or Chinese-speaking participants from the intervention group of a clinical study were recruited via purposive sampling between April 2021 and February 2022. Semistructured individual phone interviews were conducted, audio-recorded, and transcribed verbatim. Thematic analysis was performed to identify key patterns of experience, focusing on usability, emotional impact, perceived value, and areas for future improvement. RESULTS Overall, 4 main themes and 11 subthemes emerged from this study: (1) navigating the app with confidence and comfort, (2) making sense of treatment through relevant and evolving content, (3) finding emotional anchors in a time of uncertainty, and (4) advocating for broader use and continued motivation. Participants found the app user-friendly and appreciated its structure and locally relevant content, which helped reduce anxiety and enhance surgical preparedness. Features such as deep breathing exercises, motivational quotes, survivor stories, mindfulness practices, and peer support links offered emotional comfort and a sense of companionship. Participants strongly advocated for more personalized and adaptive content aligned with their treatment type and recovery progress. They also emphasized the value of interactive elements, such as video demonstrations and accessing messaging functions, to support sustained engagement. Many expressed the need for extended support throughout the adjuvant treatment phases, including chemotherapy and radiotherapy. CONCLUSIONS The iCareBreast app was perceived as a supportive tool during the perioperative period, helping patients navigate both informational and emotional challenges. However, the findings underscore the importance of extending content across the treatment continuum and enhancing personalization and interactivity. mHealth interventions should be responsive to patients’ evolving needs and integrated into clinical care pathways to provide timely, comprehensive, tailored, and ongoing support for women with breast cancer.

  • Open Access

    Effectiveness of an Innovative Mobile-Based Perioperative Care Program for Women Undergoing Breast Cancer Surgery (iCareBreast): Randomized Controlled Trial (Preprint)

    by Yan Pang, Honggu He, Ruey-Pyng Ng, Nicole Kim Luan Lee, Me Me Win Htein, Xiao-Xin Zhao, Ying-Hong Li, Elizabeth Jiahui Chan, Lixia Zhu, Guang Yu Liu, et al.

    BACKGROUND Breast cancer is one of the most prevalent cancers among women and significantly impacts psychological well-being and health-related quality of life (HR-QoL) during the perioperative period. Mobile health interventions offer a promising approach to providing education and psychosocial support, yet their effectiveness in this context remains underexplored. OBJECTIVE This study aimed to develop and evaluate the effectiveness of an innovative, mobile-based, perioperative care program for women undergoing breast cancer surgery (iCareBreast). The assessment focused on perioperative self-efficacy, anxiety, depression, fatigue, HR-QoL, and perioperative care satisfaction. METHODS A two-group randomized control trial was conducted at a tertiary hospital in Singapore. The intervention group used the iCareBreast app, offering four main resources: perioperative care guidance, breast cancer and surgery education, psychological support, and social support. The control group received standard hospital care. Participants in the intervention group engaged with the fully automated app daily for 29 days (two weeks before surgery, on the day of surgery, and two weeks after surgery). Data were collected face-to-face or on the web at three time points: baseline, immediately after the intervention (T1; two weeks after surgery), and at a 2.5-month follow-up (T2; three months after surgery). The primary outcome was perioperative care self-efficacy, while secondary outcomes included anxiety, depression, fatigue, HR-QoL, and perioperative care satisfaction. RESULTS A total of 123 patients with early-stage breast cancer scheduled for breast surgery were enrolled in the study, with 62 patients assigned to the iCareBreast group and 61 patients to the control group. The results showed no significant differences between the groups in the primary outcome—perioperative self-efficacy—at any time point. Baseline scores were similar (P=.80), and while the iCareBreast group showed slightly lower scores at T1 (mean difference [MD] –1.63, 95% CI –3.43 to 0.18; P=.08) and T2 (MD –1.90, 95% CI –4.06 to 0.26; P=.09), the differences were not statistically significant. Similarly, secondary outcomes, including anxiety, depression, fatigue, HR-QoL, and perioperative care satisfaction, showed no significant changes between groups (all P>.05). However, the iCareBreast group reported higher perioperative care satisfaction during the postintervention assessment. Satisfaction scores were comparable at T1 (P=.68), while at T2, the iCareBreast group showed a slight increase compared to the control group (MD 0.35, 95% CI 0.04-0.73; P=.08), though the difference was not statistically significant. CONCLUSIONS The mobile-based psychosocial intervention, although satisfied by users, did not demonstrate significant benefits compared to standard care. This highlights the need to refine the iCareBreast app in future iterations to enhance its effectiveness in addressing the targeted health outcomes. Future mobile health research should prioritize optimizing user engagement strategies and incorporating personalized approaches to better address the perioperative care needs of patients with breast cancer. CLINICALTRIAL ClinicalTrials.gov NCT04172350; https://clinicaltrials.gov/study/NCT04172350

  • Open Access

    Patient and family engagement interventions in primary care patient safety: a systematic review and meta-analysis

    by Yan Pang, Anna Szücs, Ignacio Ricci Cabello, Jaheeda Gangannagaripalli, Lay Hoon Goh, Foon Leng Leong, Li Fan Zhou, Jose M. Valderas

    Importance: Engaging patients and their families has been proposed and promoted as a key strategy for improving patient safety of health systems. However, little is known about the use of this approach in the primary care settings. Objective: This systematic review and meta-analysis assessed the effectiveness of interventions promoting patient and family engagement for patient safety in primary care based on randomised controlled trials (RCTs). Data Sources: Five electronic databases (MEDLINE, CINAHL, Embase, Web of Science, and CENTRAL) were searched from inception to February 2023 with key words structured in four blocks (patient and family engagement; patient safety; primary care; randomised controlled trial). Study Selection: Definition of patient safety included adverse events and non-recommended practices. Two independent study team members screened each record, with discrepancies resolved by consensus. Data Extraction and Synthesis: Reporting followed PRISMA standards and included risk of bias and level of certainty assessments. For studies reporting on similar safety outcomes, results were combined into meta-analyses using multi-level random-effects models in case of moderate/substantial heterogeneity (30%≤I²≤75%), and fixed-effect models when heterogeneity was low (I²≤30%). Main Outcome(s) and Measure(s): Expected primary study outcomes were adverse events, non-recommended medical practices, and medical errors. Interventions were considered of interest, if they prompted patients and/or families to take actions, focused on patient education about engagement, or had a significant patient engagement component if they were multifaceted interventions. Interventions were rated based on increasing degrees of patient/family engagement as “Inform about engagement”, “Empower”, and “Partner/Integrate”. Results: Sixteen records were identified, among which eight completed RCTs. No intervention reached the highest engagement level. RCTs primarily targeted medication safety outcomes, with meta-analyses showing no significant effects on adverse drug events (OR=0.73, 95%CI [0.46,1.15]) and medication appropriateness using categorical (OR=0.97, 95%CI [0.73,1.17]) and continuous outcome variables (MD=0.56, 95%CI [-0.61, 1.72]). Overall risk of bias was low and the certainty of evidence ranged from moderate to high for most completed studies. Conclusion and Relevance: Patient and family engagement strategies in primary care show inconclusive results based on extant randomised controlled evidence. They should delve into more comprehensive levels of engagement and address more diverse patient safety outcomes. Key points: Question: Is there randomised controlled evidence supporting the use of patient and family engagement interventions in primary care patient safety? Findings: Randomised controlled interventions targeting patient safety through patient and family engagement are scarce in primary care, mostly focus on medication safety, and stay at low to intermediate levels of patient and family engagement. Although their combined effectiveness did not reach significance in meta-analyses, favourable results were reported for several patient safety outcomes. Meaning: Patient and family engagement interventions for patient safety in primary care show inconclusive results based on the randomised controlled evidence at hand, yet their scarcity and relatively low level of patient/family engagement underscores the need to further test and refine such approaches in all patient safety domains.

  • Open Access

    Preliminary Effects of a Mobile Interactive Supervised Therapy Intervention on People Living With HIV: Pilot Randomized Controlled Trial

    by Yan Pang, James Steven Molton, Wei Tsang Ooi, Nicholas Iain Paton, Hong-Gu He

    Background: As people living with HIV infection require lifelong treatment, nonadherence to medication will reduce their chance of maintaining viral suppression and increase the risk of developing drug resistance and HIV transmission. Objective: This study aimed to evaluate the efficacy of a mobile app, Mobile Interactive Supervised Therapy (MIST), for improving adherence to oral HIV medications among HIV-infected adults in Singapore. Methods: We conducted a two-group pilot randomized controlled trial (RCT) with a process evaluation, in which 40 HIV-infected participants with once-daily medication regimes were recruited from a public tertiary hospital in Singapore and randomly assigned equally to either the intervention (receiving MIST and routine care) or control (receiving routine care only) groups. The intervention lasted for 2 months. The outcome of antiretroviral therapy (ART) adherence was measured by a 7-day recall self-report (SR), pill count (PC), an electronic medical device—Medication Event Monitoring System (MEMS)—and a mobile app—MIST (for the intervention group only). In total, 20 participants from the intervention group were interviewed at the end of the intervention to assess the acceptability of MIST. Data were collected at baseline and at 1-month and 2-month postintervention. Results: All participants had excellent medication adherence at baseline (median 100, IQR 100-100). The use of MIST did not result in a significant improvement in ART adherence when measured by the SR, PC, and MEMS, as compared with the control group at 1-month (P values >.99, .86, and .74, respectively) and 2-month (P values=.80, .84, and .82, respectively) postintervention. ART adherence also did not improve in each group over the same period. MIST was perceived to be a beneficial tool based on the process evaluation results. Conclusions: Although MIST did not enhance medication adherence to HIV treatments, mainly owing to the ceiling effect, it was perceived to be beneficial among the participants of this study. Our process evaluation provided useful data to further develop MIST for bigger and long-term mobile phone app–assisted intervention RCTs in the future. Trial Registration: ClinicalTrials.gov NCT03794648; https://clinicaltrials.gov/ct2/show/NCT03794648